NANOVIRICIDES, INC. — Director's Dealing 2009

Nov 18, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOVIRICIDES, INC. (NNVC.OB)
CIK: 0001379006
Period of Report: 2009-11-16

Reporting Person: Theracour Pharma, Inc. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-11-16	Common Stock	S	30000	$0.87	Disposed	33799500	Direct
2009-11-17	Common Stock	S	10000	$0.88	Disposed	33789500	Direct

Footnotes

F1: Represents shares of common stock sold in accordance with TheraCour?s Rule 10b5-1 Trading Plan adopted with the Registrant as disclosed on Form 8-K on February 10, 2009.